Arcutis shares down after earnings report
Westlake Village-based Arcutis Biotherapeutics suffered a net loss in the first quarter of fiscal year 2021, but continues to hold a strong financial position with $446.5 million in assets. According to earnings released May 4, Arcutis lost $36 million in the first quarter, or 76 cents per share, compared to a loss of $28 million, Read More →
Read More →Atara beats estimates with loss in Q1
Atara Biotherapeutics had a net loss of $78.2 million in the first quarter of fiscal year 2021, slightly higher compared than same quarter a year earlier, when the company had a loss of $73.5 million. Despite this, Atara, an immunotherapy biotech company based in South San Francisco with some of its major operations in Thousand Read More →
Read More →
H-1B freeze lifted, but most foreign workers still locked out
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Thousand Oaks biotech firm closes $140M funding round
Capsida Biotherapeutics, a biotechnology startup based in Thousand Oaks, announced April 29 that it is emerging from “stealth mode” with a $140 million funding round led by Westlake Village BioPartners and Versant Ventures. The Series A round includes $50 million from Westlake Village BioPartners, a venture capital firm in Thousand Oaks focused on biotech startups Read More →
Read More →Cal Poly to get $5M in federal funds for drone project
Cal Poly San Luis Obispo will get $5 million in federal funds to form a partnership with the Air Force Research Laboratory to study drone technology. U.S. Rep. Salud Carbajal, D-Santa Barbara, was one of three reps who helped direct $10 million to Cal Poly SLO and Cal Poly Pomona in the Consolidated Appropriations Act Read More →
Read More →Teledyne shares up on earnings news as Flir acquisition draws nearer
Teledyne Technologies saw growth in nearly all markets during the first quarter of 2021, helping the company beat expectations and deliver positive results on its first earnings report of the year. Teledyne, a Thousand Oaks-based industrial and scientific conglomerate, reported an adjusted earnings per share of $3.02 for the first quarter of 2021, beating Zacks’ Read More →
Read More →Amgen stock tumbles after earnings report
Editor’s note: This article was updated at 8:35 a.m. on April 28 with up-to-date information on Amgen’s stock price. Amgen’s shares fell nearly 8% following the company’s April 27 release of its first quarter 2021 earnings, which saw a decline in both revenue and net income compared to a year earlier. Amgen is headquartered in Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
